VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.85) per share which missed the analyst consensus estimate of $(0.57) by 49.12 percent. This is a 1316.67 percent decrease over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $398.657 thousand which missed the analyst consensus estimate of $482.667 thousand by 17.41 percent. This is a 1.97 percent decrease over sales of $406.688 thousand the same period last year.